2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Hematologic Neoplasms
2
COVID-19
2
Skin Neoplasms
1
Respiratory Sounds
1
Respiratory Distress Syndrome
1
Pneumonia, Viral
1
Pharmacokinetics
1
Neoplasms
1
Lymphoma, Follicular
1
Cytokine Release Syndrome
1
Crohn Disease
1
Bronchiolitis Obliterans Syndrome
1
Asthma
1
Adenomatous Polyposis Coli
1
Interventions
Celecoxib
7
Biopsy
5
Sulindac
4
Specimen Handling
3
Eflornithine
3
Curcumin
3
guselkumab
2
Ursodeoxycholic Acid
2
Surveys and Questionnaires
2
Sirolimus
2
Sigmoidoscopy
2
Gastroscopy
2
Erythromycin
2
Erlotinib Hydrochloride
2
Endoscopy, Gastrointestinal
2
Endoscopy, Digestive System
2
Endoscopy
2
Colonoscopy
2
trifluridine tipiracil drug combination
1
rofecoxib
1
obeticholic acid
1
Thiamine
1
Surgical Procedures, Operative
1
Suppositories
1
Probiotics
1
Polymorphism, Single-Stranded Conformational
1
Polymerase Chain Reaction
1
Pharmaceutical Preparations
1
Oxaliplatin
1
Nivolumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Adenomatous Polyposis Coli
×
Azithromycin
×
Clear all
NCT04454151
2020-07-01
FAP
Tel-Aviv Sourasky Medical Center
Phase 4
Unknown
10 enrolled